Table 1.
Correlation of Plexin C1 staining with clinicopathological characteristics of the patients.
| Plexin C1 Staining | |||||
|---|---|---|---|---|---|
| N | Negative | Weak | Strong | P | |
| Age | |||||
| ≤60 | 65 | 10 (15.38%) | 12 (18.46%) | 43 (66.15%) | |
| >60 | 25 | 5 (20%) | 6 (24%) | 14 (56%) | 0.67 |
| Gender | |||||
| F | 16 | 3 (18.75%) | 4 (25%) | 9 (56.25%) | |
| M | 74 | 12 (16.22%) | 14 (18.92%) | 48 (64.86%) | 0.799 |
| Stage | |||||
| 1&2 | 52 | 11 (21.15%) | 8 (15.38%) | 33 (63.46%) | |
| 3 | 31 | 4 (12.9%) | 8 (25.81%) | 19 (61.29%) | 0.398 |
| Grade | |||||
| Well-Differentiated | 65 | 13 (20%) | 9 (13.85%) | 43 (66.15%) | |
| Poorly-Differentiated | 25 | 2 (8%) | 9 (36%) | 14 (56%) | 0.043 |
| Disease Status | |||||
| HCC with cirrhosis | 16 | 5 (31.25%) | 2 (12.5%) | 9 (56.25%) | |
| HCC | 74 | 10 (13.51%) | 16 (21.62%) | 48 (64.86%) | 0.204 |
N: number of cases. Correlation analyses were carried out with chi-square test. Plexin C1 staining was classified according to H-scores as follows: 0 = negative; 1-6 = weak; 7-12 = strong.